1.One Stage Posterior Minimal Laminectomy and Video-Assisted Thoracoscopic Surgery (VATS) for Removal of Thoracic Dumbbell Tumor.
Kyoung Hyup NAM ; Hyo Yeoung AHN ; Jeong Su CHO ; Yeoung Dae KIM ; Byung Kwan CHOI ; In Ho HAN
Journal of Korean Neurosurgical Society 2017;60(2):257-261
OBJECTIVE: This study was conducted to assess the surgical results of one-stage posterior minimal laminectomy and video-assisted thoracoscopic surgery (VATS) for the treatment of thoracic dumbbell tumor and to describe its precise technique. In addition, we investigated the technique's usefulness and limitations. METHODS: Seven cases of thoracic dumbbell tumor (two men and five women, mean age, 43 years) were analyzed retrospectively. Pathological findings included schwannoma in four patients, neurofibroma in two patients, and hemangioma in one patient. The location of tumors varied from T2/3 to T12/L1. Dumbbell tumors were resected by one-stage operation using posterior laminectomy followed by VATS without instrumentation. Clinical data were reviewed. RESULTS: The mean follow-up period was 25 months (range, 3–58 months), and the operative time ranged from 255 to 385 min (mean, 331 min), with estimated blood loss ranging from 110 to 930 mL (mean, 348 mL). The tumor was completely resected without instrumentation and postoperative instability in all cases. Postoperative complications included atelectasis and facial anhydrosis in one case each. CONCLUSION: One-stage posterior minimal laminectomy and VATS may be a safe and less invasive technique for removal of thoracic dumbbell tumor without instability. This method has the advantage of early ambulation and rapid recovery because it reduces blood loss and postoperative pain.
Early Ambulation
;
Female
;
Follow-Up Studies
;
Hemangioma
;
Humans
;
Laminectomy*
;
Male
;
Methods
;
Neurilemmoma
;
Neurofibroma
;
Operative Time
;
Pain, Postoperative
;
Postoperative Complications
;
Pulmonary Atelectasis
;
Retrospective Studies
;
Thoracic Surgery, Video-Assisted*
2.A Case of Diabetes Insipidus in Patient with Sheehan's Syndrome
Hye Young PARK ; Moon Ho KANG ; Sung Gwang LEE ; Jung Ho YOUN ; Yeoung Sook KANG ; Deuk Jo KIM ; Yun Young CHOI ; Hee Young HWANG
Journal of Korean Society of Endocrinology 1996;11(1):108-113
Sheehans syndrome is a known complication of pregnancy, It was described as a syndrome of hypopituitarysm due to acute ischemic necrosis of the anterior pituitary gland secondary to severe postpartum bleeding and shock. The neurophysis is usually preserved. But it can be involved in severe cases manifesting as diabetes insipidus. Because of its rare coexistence with Sheehans syndrome, diabetes insipidus is seldom recognized as a potential postpartum complication. The report describes a patient who developed Sheehans syndrome and diabetes insipidus immediately following delivery. Diabetes insipidus resolved spontaneously after 15 months, while panhypopituitarysm is persistent.
Diabetes Insipidus
;
Hemorrhage
;
Humans
;
Hypopituitarism
;
Necrosis
;
Pituitary Gland, Anterior
;
Postpartum Hemorrhage
;
Postpartum Period
;
Pregnancy
;
Shock
3.Nocturnal Arterial Oxygen Saturation Monitoring in Patients with Respiratory Disease.
In Seon CHOI ; Jae Beom YANG ; Young Chul KIM ; Ik Joo CHUNG ; Yu Ho KANG ; Yeoung Il KOH ; Sang Seon PARK ; Min Su LEE ; Kyung Ok PARK
Tuberculosis and Respiratory Diseases 1994;41(2):103-110
To find out the predictors of nocturnal arterial oxygen desaturation in patients with respiratory diseases, transcutaneous oxygen saturation(StcO2) monitoring studies using a pulse oximeter were performed during sleep in 20 patients. StcO2 was decreased more than 4% from the baseline value in 18 patients(90%) and more than 10%('Desaturator') in 8(40%). Five of the seven patients(71.4%) with awake PaO2<60mmHg and three of the thirteen patients(23.1%) with awake PaO2≥60mmHg were 'desaturators'. The awake PaO2/FIO2 and PaO2/PAO2 could distinguish 'desaturator' from 'nondesaturator, and PaO2, SaO2 or StcO2 could not. These results suggest that the nocturnal oxygen desaturation depends on the severity of the underlying disease rather than the baseline PaO2. Anthropomorphic and lung function factors could not separate between 'desaturator' and 'non-desaturator', and about a quarter of patients with a wake PaO2≥60mmHg developed significant desaturation. Therefore, it is necessary to monitor the nocturnal arterial oxygen saturation in patients with respiratory diseases regardless of their severity of airflow obstruction or awake PaO2.
Humans
;
Lung
;
Oxygen*
4.Phase II Study of Paclitaxel and Cisplatin as Second-line Chemotherapy in Advanced Non-small Cell Lung Cancer.
Yeoung Tae SEO ; Bong Seog KIM ; Ji Young GO ; Dong Suk CHOI ; Seong Ho CHOI ; Hye Jin KIM ; Young Mi AHN ; Yong Ho ROH ; Kyung Hee LEE
Yeungnam University Journal of Medicine 2004;21(2):198-206
BACKGROUND: To evaluate the efficacy and safety of paclitaxel and cisplatin against advanced non-small cell lung cancer (NSCLC) as a second-line chemotherapy. SUBJECTS AND METHODS: Twenty-five patients were enrolled. The patients received 200 mg/m2 paclitaxel as a 3-hour intravenous infusion and 60 mg/m2 cisplatin as 30-minute intravenous infusion with vigorous hydration on day 1 every 28 days. The response was assessed every 2 cycles. RESULTS: All 25 patients were assessed for their response and toxicity. Partial responses were observed in 5 patients. The overall response rate was 20% (95% confidence interval, 4%~36%) and the median response duration was 4.5 (range, 2-11) months. The median time to progression was 3.3 (range, 0-14) months. The median overall survival of all patients was 7.4 (range, 1.3-39) months. The hematologic toxicities were minor and easily controlled. CONCLUSION: The combination chemotherapy of paclitaxel and cisplatin as a second-line treatment has a moderate efficacy with an acceptable toxicity in patients with advanced NSCLC.
Carcinoma, Non-Small-Cell Lung*
;
Cisplatin*
;
Drug Therapy*
;
Drug Therapy, Combination
;
Humans
;
Infusions, Intravenous
;
Paclitaxel*
5.10 Year-Experience of Endoscopic Thyroidectomy for Papillary Thyroid Microcarcinoma in Single Institution: Breast Approach and Gasless Transaxillary Approach.
Yeoung Eun KIM ; Ha Na KWAK ; Jun Ho KIM ; Yoon Jung CHOI ; Ji Sup YUN ; Byung Ho SON ; Yong Lai PARK
Journal of the Korean Surgical Society 2010;79(5):326-331
PURPOSE: Endoscopic thyroid surgery has been widely used because of the cosmetic advantage and the development of laparoscopic instruments. We have performed endoscopic thyroidectomy by breast approach and gasless transaxillary approach on papillary thyroid microcarcinomas. In this study, we describe these two types of endoscopic procedures with the technique of the method and surgical outcomes. METHODS: From Oct. 1999 to Oct. 2009, each procedure was performed in 162 patients divided into two groups. Breast approach group was in 91 patients and gasless transaxillary approach group was in 71 patients. We compared the results of mean ages, sex ratio, extent of operation, mean hospital stay, operating time, pathologic characteristics and postoperative complications between the breast approach group and gasless transaxillary approach group. RESULTS: Ninety-one cases treated using breast approach, and seventy-one cases treated using gasless transaxillary approach. The operation time was 197.4+/-60.7 minutes (95~350) in breast approach group, and 100.1+/-19.8 minutes (65~140) in gasless transaxillary approach group. Post operative complications are; 2 cases of transient hoarseness, 8 cases of hypocalcemia (including 2 cases of permanent hypocalcemia), 2 cases of chest wall discomfort in breast approach group, and 1 case of transient hoarseness, 2 cases of transient hypocalcemia, 1 case of postoperative bleeding in gasless axillary approach group. CONCLUSION: Endoscopic thyroidectomy is a safe and technically feasible alternative to conventional thyroidectomy in patients with benign and highly selected malignant disease. We expect it can increase the extent of surgery.
Breast
;
Carcinoma, Papillary
;
Cosmetics
;
Hemorrhage
;
Hoarseness
;
Humans
;
Hypocalcemia
;
Imidazoles
;
Length of Stay
;
Nitro Compounds
;
Postoperative Complications
;
Sex Ratio
;
Thoracic Wall
;
Thyroid Gland
;
Thyroid Neoplasms
;
Thyroidectomy
6.A Case of Vanishing Bile Duct Syndrome Associated with Hypersensitivity to Allopurinol.
Seong Ho CHOI ; Soo Hyun YANG ; Young Bong SONG ; Hye Jin KIM ; Yeoung Tae SEO ; Dong Seog CHOI ; Kyoung Hyoub MOON ; Jong Hoon BYUN ; Eun Sil YU
The Korean Journal of Hepatology 2005;11(1):80-85
Allopurinol is frequently used for the treatment of hyperuricemia and gout. Sometimes, a life-threatening reaction develops, as is illustrated by the following case report. We describe a 60-year-old male patient who was treated with allopurinol because of asymptomatic hyperuricemia, and he was presented with fever, skin rash, eosinophilia, worsening renal function and vanishing bile duct syndrome. In this report, we discussed vanishing bile duct syndrome as a serious side effect of allopurinol, and we briefly reviewed the etiology, prevention, and treatment modalities for vanishing bile duct syndrome.
Allopurinol/*adverse effects
;
Bile Duct Diseases/*etiology/pathology
;
Drug Hypersensitivity/*complications
;
English Abstract
;
Gout Suppressants/*adverse effects
;
Humans
;
Male
;
Middle Aged
7.Phase II Study to Topotecan and Cisplatin in Advanced Hepatocellular Carcinoma.
Ga Young LEE ; Bong Seog KIM ; Yeoung Tae SEO ; Seong Ho CHOI ; Hye Jin KIM ; Dong Seog CHOI ; Ji Young KO ; Soo Hyun YANG ; Jong Hoon BYUN
The Korean Journal of Internal Medicine 2003;18(2):104-108
BACKGROUND: Hepatocellular carcinoma remains a highly chemoresistant neoplasm and is a common malignancy with poor prognosis in Korea. We performed a phase II study to evaluate the efficacy and toxicities of topotecan and cisplatin combination chemotherapy for advanced hepatocellular carcinoma. METHODS: Between November 1999 and May 2001, ten patients with histologically proven hepatocellular carcinoma were enrolled in this study. The median age was 54 (range: 53~74) years and all were male. Six patients demonstrated stage IV, 1 stage IIIC, 2 stage IIIB and 1 stage IIIA. Six patients showed a ECOG performance status of 1. The treatment regimen consisted of topotecan 1.25 mg/m2 and cisplatin 20 mg/m2 for 5 days. The treatment was repeated every 4 weeks. Toxicities were evaluated according to WHO toxicity criteria. RESULTS: All ten patients were evaluable for response and toxicity. There was only one patient who achieved partial response. The overall response rate was 10% (95% C.I.) and the response duration was 46 weeks. The median survival of all patients was 21 (range: 17~54+) weeks. During a total of 24 cycles, neutropenia of WHO grade 3 and 4 occurred in 33%, thrombocytopenia in 33% and anemia in 21%. In non-hematologic toxicity, diarrhea and hepatoxicity of grade 3 occurred in 1 and 2 patients, respectively. But there was no treatment-related death. CONCLUSION: When used in this dose and schedule, topotecan and cisplatin combination chemotherapy does not seem to be effective for patients with advanced hepatocellular carcinoma.
Aged
;
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
;
Carcinoma, Hepatocellular/*drug therapy
;
Cisplatin/*administration & dosage
;
Human
;
Liver Neoplasms/*drug therapy
;
Male
;
Middle Aged
;
Topotecan/*administration & dosage
;
Treatment Outcome
8.Morphological Variation of the Kidney Secondary to Junctional Parenchyma on Ultrasound.
Ji Yoon LEE ; Byeong Ho PARK ; Kyeong Jin NAM ; Jong Cheol CHOI ; Bong Sig KOO ; Jou Yeoung KIM ; Seung Eon AHN ; Yung Il LEE
Journal of the Korean Radiological Society 1996;34(4):527-531
PURPOSE: To evaluate the prevalance of morphological variation of the kidney secondary to junctional parenchyma, as well as to analyze the ultrasonographic features of junctional parenchyma. MATERIALS AND METHODS: Two hundred and eighty two kidneys of 141 patient without clinical or radiologic evidence of renal disease were prospectively analysed using ultrasound. In all patients, ultrasonograms were obtained in sagittal, coronal and transaxial planes. The kidney was considered to have morphological variation if the ulrasonogram demonstrated junctional parenchymal defect or line ; those showing such variation were classified as one of three types :continuous, discontinuous, or junctional parenchymal line or defect without junctional parenchyma. The prevalance and ultrasonographic features of the kidneys were evaluated. RESULTS: Morphological variation was noted in 71 cases(25%). the continuous type accounted for 54% of these, the discontinuous type for 38%, and junctional parenchymal defect or line without junctional parenchyma for 8%. In all cases, junctional parenchyma was located approximately at the junction of the upper and middle third of the kidny, and had the same echogenecity as the renal cortex. CONCLUSION: An understanding of the morphological variation of the kidney resulting from junctional renal parenchyma would be helpful in differentiating pseudo tumor from true renal neoplasm.
Humans
;
Kidney Neoplasms
;
Kidney*
;
Ultrasonography*
9.In Vitro Activities of Daptomycin Against Recent Clinical Isolates of Methicillin-resistant Staphylococci and Vancomycin-resistant Enterococci in Korea.
Hyukmin LEE ; Seo Jin PARK ; Yeoung Seon CHOI ; Doe Young PARK ; Kyoung Ho ROH ; Jong Hwa YUM ; Dongeun YONG ; Kyungwon LEE ; Yun Sop CHONG
Infection and Chemotherapy 2006;38(2):85-90
BACKGROUND: Daptomycin is a novel cyclic lipopeptide antibiotic that exhibits in vitro bactericidal activity against gram-positive pathogens including methicillin-resistant staphylococci and vancomycin-resistant enterococci. The aim of this study is to determine the in vitro activities of daptomycin against recent clinical isolates of methicillin-resistant staphylococci and vancomycin-resistant enterococci in Korea. MATERIALS AND METHODS: A total of 117 clinical strains of methicillin-resistant staphylococci and vancomycin-resistant enterococci were isolated at a tertiary-care hospital in Korea in 2004. Susceptibility to daptomycin was tested by the CLSI broth microdilution method using Mueller-Hinton broth (MHB) which was adjusted to contain a final concentration of 50 microgram/mL of ionized calcium (Ca2+). Susceptibilities to ampicillin, oxacillin, levofloxacin, vancomycin, and linezolid were tested by the CLSI agar dilution method. RESULTS: All isolates of methicillin-resistant S. aureus and coagulase-negative staphylococci were inhibited by 1 microgram/mL of daptomycin, and MIC90s were 1 microgram/mL, which were similar to those of vancomycin and linezolid. MIC90s of daptomycin for vancomycin-resistant E. faecalis and E. faecium were 0.5 microgram/mL and 2 microgram/mL, respectively, and all isolates were susceptible to daptomycin. MIC90s of linezolid and levofloxacin for vancomycin-resistant enterococci were 1-2 microgram/mL and 64 microgram/mL, respectively. Resistance rates of vancomycin-resistant E. faecalis and E. faecium to levofloxacin were 100% and 96%, respectively. Daptomycin MICs in MHB supplemented to 20-25 microgram/ml of Ca2+ were 2-8 fold higher than those in MHB supplemented to 50 microgram/mL of Ca2+. CONCLUSION: Daptomycin is very active in vitro against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in Korea, and it is important to test in vitro activity of daptomycin using MHB containing 50 microgram/mL of Ca2+.
Agar
;
Ampicillin
;
Calcium
;
Daptomycin*
;
Korea*
;
Levofloxacin
;
Linezolid
;
Methicillin Resistance*
;
Methicillin-Resistant Staphylococcus aureus
;
Oxacillin
;
Vancomycin
10.In Vitro Activities of Daptomycin Against Recent Clinical Isolates of Methicillin-resistant Staphylococci and Vancomycin-resistant Enterococci in Korea.
Hyukmin LEE ; Seo Jin PARK ; Yeoung Seon CHOI ; Doe Young PARK ; Kyoung Ho ROH ; Jong Hwa YUM ; Dongeun YONG ; Kyungwon LEE ; Yun Sop CHONG
Infection and Chemotherapy 2006;38(2):85-90
BACKGROUND: Daptomycin is a novel cyclic lipopeptide antibiotic that exhibits in vitro bactericidal activity against gram-positive pathogens including methicillin-resistant staphylococci and vancomycin-resistant enterococci. The aim of this study is to determine the in vitro activities of daptomycin against recent clinical isolates of methicillin-resistant staphylococci and vancomycin-resistant enterococci in Korea. MATERIALS AND METHODS: A total of 117 clinical strains of methicillin-resistant staphylococci and vancomycin-resistant enterococci were isolated at a tertiary-care hospital in Korea in 2004. Susceptibility to daptomycin was tested by the CLSI broth microdilution method using Mueller-Hinton broth (MHB) which was adjusted to contain a final concentration of 50 microgram/mL of ionized calcium (Ca2+). Susceptibilities to ampicillin, oxacillin, levofloxacin, vancomycin, and linezolid were tested by the CLSI agar dilution method. RESULTS: All isolates of methicillin-resistant S. aureus and coagulase-negative staphylococci were inhibited by 1 microgram/mL of daptomycin, and MIC90s were 1 microgram/mL, which were similar to those of vancomycin and linezolid. MIC90s of daptomycin for vancomycin-resistant E. faecalis and E. faecium were 0.5 microgram/mL and 2 microgram/mL, respectively, and all isolates were susceptible to daptomycin. MIC90s of linezolid and levofloxacin for vancomycin-resistant enterococci were 1-2 microgram/mL and 64 microgram/mL, respectively. Resistance rates of vancomycin-resistant E. faecalis and E. faecium to levofloxacin were 100% and 96%, respectively. Daptomycin MICs in MHB supplemented to 20-25 microgram/ml of Ca2+ were 2-8 fold higher than those in MHB supplemented to 50 microgram/mL of Ca2+. CONCLUSION: Daptomycin is very active in vitro against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in Korea, and it is important to test in vitro activity of daptomycin using MHB containing 50 microgram/mL of Ca2+.
Agar
;
Ampicillin
;
Calcium
;
Daptomycin*
;
Korea*
;
Levofloxacin
;
Linezolid
;
Methicillin Resistance*
;
Methicillin-Resistant Staphylococcus aureus
;
Oxacillin
;
Vancomycin